| Accession | Title | Series type(s) | Organism(s) | Samples | GDS | Supplementary | Contact | Release date |
|---|---|---|---|---|---|---|---|---|
 Filter
|
Megathura crenulata
|
|||||||
| GSE42019 |
Baseline serum anti-glycan antibodies of 28 subjects in a clinical trial of PROSTVAC-VF, a therapeutic cancer vaccine [Training IgG 1:50]
|
28 | Christopher Campbell | Apr 01, 2013 | ||||
| GSE42020 |
Baseline serum anti-glycan antibodies of 28 subjects in a clinical trial of PROSTVAC-VF, a therapeutic cancer vaccine [Training IgM 1:50]
|
28 | Christopher Campbell | Apr 01, 2013 | ||||
| GSE42145 |
Baseline serum anti-glycan antibodies of 28 subjects in a clinical trial of PROSTVAC-VF, a therapeutic cancer vaccine [Training Total Ig 1:50]
|
28 | Christopher Campbell | Apr 01, 2013 | ||||
| GSE42150 |
Baseline serum anti-glycan antibodies of 28 subjects in a clinical trial of PROSTVAC-VF, a therapeutic cancer vaccine [Training Total Ig 1:200]
|
28 | Christopher Campbell | Apr 01, 2013 | ||||
| GSE42163 |
Baseline serum anti-glycan antibodies of 113 subjects in a clinical trial of PROSTVAC-VF, a therapeutic cancer vaccine [Validation IgG 1:50]
|
113 | Christopher Campbell | Apr 01, 2013 | ||||
| GSE42175 |
Baseline serum anti-glycan antibodies of 113 subjects in a clinical trial of PROSTVAC-VF, a therapeutic cancer vaccine [Validation IgM 1:50]
|
113 | Christopher Campbell | Apr 01, 2013 | ||||
| GSE42176 |
Baseline serum anti-glycan antibodies of 113 subjects in a clinical trial of PROSTVAC-VF, a therapeutic cancer vaccine [Validation Total Ig 1:50]
|
113 | Christopher Campbell | Apr 01, 2013 | ||||
| GSE42179 |
Baseline serum anti-glycan antibodies of 113 subjects in a clinical trial of PROSTVAC-VF, a therapeutic cancer vaccine [Validation Total Ig 1:200]
|
113 | Christopher Campbell | Apr 01, 2013 | ||||
| GSE42184 |
Baseline serum anti-glycan antibodies of 113 subjects in a clinical trial of PROSTVAC-VF, a therapeutic cancer vaccine
|
564 | Christopher Campbell | Apr 01, 2013 |
